Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
SYNCOMF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Syncom Formulations India Ltd has informed exchanges that its Board of Directors meeting is scheduled for May 22, 2026 at 3:00 PM at their Indore corporate office. The meeting will consider and approve the standalone and consolidated audited financial results for Q4 and the full year ended 31st March 2026. The board will also take on record the audit reports from auditors and review the complete financial statements including Statement of Assets & Liabilities, Profit and Loss account, Cash Flows, and Statement of Changes in Equity. The company filed this intimation under SEBI LODR Regulation 29(1)(a).
This is a routine pre-results announcement. The actual impact on the stock will depend on whether the Q4 and full-year results beat, meet, or miss market expectations. Investors should wait for the results announcement post-meeting.